ArticleClinical and vaccine immunology : CVI2015

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.

Elisabeth Adderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.